TY  - JOUR
AU  - Cánovas, Manuel Sánchez
AU  - Garay, David Fernández
AU  - Moran, Laura Ortega
AU  - Pérez, Jaime Rubio
AU  - Rubio, Carlos Miguel Guirao
AU  - de Mena, Miriam Lobo
AU  - Portero, Berta Obispo
AU  - Castro, Jesús Brenes
AU  - Lage, Yolanda
AU  - Lavin, Diego Cacho
AU  - Blanco, Ana Belen Rupérez
AU  - de Soignie, Ana Manuela Martín Fernández
AU  - Perejón, Jonatan Zacarías Benoit
AU  - Colomo, Laura Jiménez
AU  - Boluda, Noel Blaya
AU  - Moreno, Javier Bosque
AU  - Verduguez, Teresa Quintanar
AU  - Garrido, Carmen Rosa
AU  - Huertas, Roberto Martín
AU  - Puig, Carme Font I
AU  - Martín, Andrés Jesús Muñoz
PY  - 2022
DO  - 10.1007/s12094-022-02860-5
UR  - http://hdl.handle.net/10668/21175
T2  - Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
AB  - Immune Checkpoint Inhibitors (ICI) can be associated with thrombotic events, both venous and arterial (VTE/AT). However, there is a paucity of information regarding patients in routine clinical practice. Retrospective, multicenter study promoted by...
LA  - en
KW  - Cancer related thrombosis
KW  - Immune Checkpoint Inhibitors
KW  - Lung cancer
KW  - Melanoma
KW  - Humans
KW  - Immune Checkpoint Inhibitors
KW  - Lung Neoplasms
KW  - Medical Oncology
KW  - Melanoma
KW  - Prognosis
KW  - Retrospective Studies
KW  - Thrombosis
KW  - Venous Thromboembolism
TI  - Immune checkpoint inhibitors-associated thrombosis in patients with lung cancer and melanoma: a study of the Spanish society of medical oncology (SEOM) thrombosis and cancer group.
TY  - research article
VL  - 24
ER  -